This is the second U.S. early feasibility study evaluating the safety of the AccuCinch® Ventricular Repair System, and it will enroll up to 15 patients from heart centers across the country.
Positive Interim Analysis from Study of First-of-Its-Kind Heart Failure Therapy Announces Ancora Heart
The data was presented at the 30th Transcatheter Cardiovascular Therapeutics (TCT), the annual scientific symposium of the Cardiovascular Research Foundation.
Ancora Heart Expands Enrollment of U.S. Early Feasibility Study for the AccuCinch System for Left Ventricular Repair
5/14/18: The company reports the study evaluates safety of first-of-its-kind therapy designed to directly target systolic heart failure.